Complex therapy of atopic keratoconjunctivitis in children
E. V Yani , V. V Pozdnyakova , L. N Yakushina , M. B Grishakova
Russian Pediatric Ophthalmology ›› 2014, Vol. 9 ›› Issue (2) : 36 -38.
Complex therapy of atopic keratoconjunctivitis in children
The purpose of the study was to evaluate the efficacy and acceptability of the drug Restasis® in treatment of atopic keratoconjunctivitis in children. The study enrolled 16 patients (32 eyes) with atopic keratoconjunctivitis at the age from 10 to 16 years. Restasis® put on 2 drops 2 times a day during 6 months. It was determined that Restasis® is well tolerated by patients, gives significant and stable therapeutic effect confirmed by long period of clinical observation. Besides, it improves dry eye symptoms, reduces the risk of complications in long-term use of corticosteroids.
atopic keratoconjunctivitis / atopic dermatitis / allergic keratitis / cyclosporine
| [1] |
Курбачева O.M. Поллинозы. Современные аспекты диагностики и лечения аллергических заболеваний. М.; 2009. |
| [2] |
Смирнова Г.И. Современные топические кортикостероиды в лечении аллергодерматозов у детей. Materia Medica. 2000; 1: 72-5. |
| [3] |
Балаболкин И.И., Гребенюк В.Н. Атопический дерматит у детей. М.; Медицина; 1999. |
| [4] |
Ревякина В.А. Атопический дерматит у детей: проблемы диагностики, классификации и клиники. Materia Medica. 2000;1: 41-9. |
| [5] |
Foster C.S., Calonge M. Atopic keratoconjunctivitis. Ophthalmology.1990; 98 (8): 992-1000. |
| [6] |
Power W.J., Tugal-Tutkin I., Foster C.S. Long-term follow-up patients with atopic keratoconjunctivitis. Ophthalmology. 1998; 105 (4): 637-42. |
Eco-Vector
/
| 〈 |
|
〉 |
PDF
